Ignite Creation Date:
2024-05-05 @ 4:35 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00278239
Status:
UNKNOWN
Last Update Posted:
2013-09-20
First Post:
2006-01-16
Brief Title:
Quality of Life in Patients Who Have Undergone Previous Treatment for Primitive Neuroectodermal Tumors
Sponsor:
Childrens Cancer and Leukaemia Group
Organization:
National Cancer Institute NCI
Study Overview
Official Title:
Study of Outcome of Children Previously Enrolled in European Trials of Treatment for Primitive Neuroectodermal Tumour PNET
Status:
UNKNOWN
Status Verified Date:
2006-04
Last Known Status:
ACTIVE_NOT_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
RATIONALE Questionnaires that measure quality of life may improve the ability to plan treatment for patients with primitive neuroectodermal tumors
PURPOSE This phase III trial is studying quality of life in patients who have undergone previous treatment for primitive neuroectodermal tumors
PURPOSE This phase III trial is studying quality of life in patients who have undergone previous treatment for primitive neuroectodermal tumors
Detailed Description:
OBJECTIVES
Primary
Determine the quality of survival of patients in the UK and other European countries enrolled in previous International Society of Pediatric Oncology SIOP 2 or 3 phase III trials for treatment of pediatric primitive neuroectodermal tumors PNET
Compare the quality of survival between children allocated to different treatments in these trials
Secondary
Determine the framework that will allow similar information to be collected across all participating countries in the PNET 4 trial that opened in autumn 2002
OUTLINE This is a cross-sectional multicenter study
Pediatric oncologists teachers patients 12 years old and parents of children age 3-11 years old complete six questionnaires to assess the patients motor and sensory function cognition behavior emotion educational provision and achievement social integration and the subjective experience of the patients and their families
PROJECTED ACCRUAL A total of 229 patients will be accrued for this study
Primary
Determine the quality of survival of patients in the UK and other European countries enrolled in previous International Society of Pediatric Oncology SIOP 2 or 3 phase III trials for treatment of pediatric primitive neuroectodermal tumors PNET
Compare the quality of survival between children allocated to different treatments in these trials
Secondary
Determine the framework that will allow similar information to be collected across all participating countries in the PNET 4 trial that opened in autumn 2002
OUTLINE This is a cross-sectional multicenter study
Pediatric oncologists teachers patients 12 years old and parents of children age 3-11 years old complete six questionnaires to assess the patients motor and sensory function cognition behavior emotion educational provision and achievement social integration and the subjective experience of the patients and their families
PROJECTED ACCRUAL A total of 229 patients will be accrued for this study
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?:
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| EU-20578 | None | None | None |
| CCLG-CNS-2002-03 | None | None | None |